Alexandria Capital »

Biogen Idec shares owned by Alexandria Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Alexandria Capital from 13F filings

Historical chart of Alexandria Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Alexandria Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Alexandria Capital

Quarter filed Position value Share count Share price at filing
2013-03-31 $4.0k 19 210.53
2012-12-31 $3.0k 19 157.89

More positions owned by Alexandria Capital

Adobe Systems Incorporated (ADBE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
Alnylam Pharmaceuticals (ALNY)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard World Mega Grwth Ind (MGK)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Facebook Cl A (META)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Comcast Corp Cl A (CMCSA)
JPMorgan Chase & Co. (JPM)
Marvell Technology (MRVL)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)

View all positions for Alexandria Capital

Top funds holding Biogen Idec

PRIMECAP Management Company
BlackRock
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Invesco
Northern Trust
RA Capital Management
Dimensional Fund Advisors
Bank of New York Mellon
Barclays
Renaissance Technologies
Susquehanna International
Charles Schwab Investment Management

View all funds holding Biogen Idec